Dalton Transactions
Paper
3 CHFlu + CHIm), 7.54–7.49 (m, 2H, CHFlu), 7.44–7.39 (m, 2H, at room temperature. The reaction was complete after less
CHFlu), 7.10 (br, 1H, CHIm), 7.09–7.08 (m, 1H, CHFlu), 7.00 (br, than 30 min as judged by TLC and all volatiles were removed
2H, CHMes), 2.61 (s, 3H, CH3 Flu-9), 2.32 (s, 3H, CH3 para), 2.12 under vacuum. The residue was purified by flash chromato-
(s, 6H, CH3 ortho); 13C{1H} NMR (75.5 MHz, CDCl3): δ = 145.0, graphy (neutral Al2O3, Brockmann’s type 3, hexane–CH2Cl2:
141.6, 139.3 (CAr), 137.3 (N2CH), 134.2 (CAr), 130.8, 130.1, 129.6 2/1 then 1/1) to yield a yellow powder (235 mg, 96%). X-Ray-
(2 CHFlu + CHMes), 124.3 (CHFlu), 124.0, 121.5 (CHIm), 121.1 quality crystals were grown by slow diffusion of pentane into a
(CHFlu), 71.8 (C(CH3)Flu-9), 25.6 (CH3 Flu-9), 21.3 (CH3 para), 18.2 CHCl3 solution of 5. 1H NMR (400 MHz, CDCl3): δ = 8.27 (d, J =
(CH3 ortho); IR (ATR): ν = 3168, 3118, 3073, 2971, 1606, 1534, 8.2 Hz, 1H, CHFlu), 8.12 (s, 1H, CHFlu-9), 7.82 (d, J = 7.5 Hz, 1H,
1478, 1444, 1216, 1186, 1154, 1087, 1031, 994, 878, 845, 770, CHFlu), 7.76 (d, J = 7.5 Hz, 1H, CHFlu), 7.50–7.42 (m, 3H, CHFlu),
744, 735 cm−1; MS (ESI): m/z (%): 365 (100) [M − I]+, 187 (56) 7.36–7.33 (m, 2H, CHFlu), 7.14 (s, 1H, CHMes), 6.96 (s, 1H,
[Mes − ImH]+; elemental analysis calcd (%) for C26H25IN2 (MW
492.40): C 63.42, H 5.12, N 5.69; found: C 63.20, H 5.08, N 5.55.
=
CHMes), 6.64 (d, J = 1.9 Hz, 1H, CHIm), 6.30 (d, J = 1.9 Hz, 1H,
CHIm), 5.00–4.96 (m, 1H, CHCOD), 4.91–4.87 (m, 1H, CHCOD),
(1-Mesityl-3-(fluoren-9-yl)imidazol-2-ylidene)gold(I) chloride 3.86–3.82 (m, 1H, CHCOD), 3.27–3.24 (m, 1H, CHCOD), 2.54 (s,
(4). Solid AuCl(tht) (63 mg, 0.196 mmol) was added all at once 3H, CH3 Mes), 2.45–2.36 (m, 1H, CH2COD), 2.41 (s, 3H, CH3 Mes),
into a solution of 2 (75 mg, 0.214 mmol, 1.1 eq.) in CH2Cl2 2.18–1.95 (m, 3H, CH2COD), 1.90 (s, 3H, CH3 Mes), 1.85–1.58 (m,
(5 mL) at −60 °C. The solution was allowed to warm up to 3H, CH2COD), 1.33–1.24 (m, 3H, CH2COD); 13C{1H} NMR
room temperature overnight. Volatiles were removed under (105.5 MHz, CDCl3): δ = 184.0 (d, JRh–C = 51.2 Hz, N2C), 144.1,
vacuum and the yellow residue was purified by flash chromato- 143.4, 141.3, 140.3, 138.9, 138.8, 137.4, 136.2, 134.5 (CAr), 129.8
graphy (SiO2, hexane–CH2Cl2: 1/1) to yield the product as a (CHMes), 129.3, 129.2, 128.6, 128.3 (CHFlu), 127.9 (CHMes), 127.8
white powder (76 mg, 67%). X-Ray-quality crystals were grown (CHFlu), 124.2 (CHIm), 124.1, 120.5, 119.7 (CHFlu), 118.8 (CHIm),
by slow diffusion of pentane into a CH2Cl2 solution of 4. 1H 98.1 (d, JRh–C = 7.5 Hz, CHCOD), 97.6 (d, JRh–C = 6.9 Hz, CHCOD),
NMR (400 MHz, CD2Cl2): δ = 7.84 (d, J = 7.6 Hz, 2H, CHFlu), 68.6 (d, JRh–C = 14.3 Hz, CHCOD), 68.3 (d, JRh–C = 14.3 Hz,
7.59–7.56 (m, 2H, CHFlu), 7.55–7.51 (m, 2H, CHFlu), 7.38 (td, J = CHCOD), 66.0 (CHFlu-9), 33.9, 32.0, 29.0, 28.3 (CH2COD), 21.5,
7.5 Hz, J = 1.1 Hz, 2H, CHFlu), 7.08 (s, 2H, CHMes), 7.02 (s, 1H, 19.9, 17.9 (CH3 Mes); IR (ATR): ν = 2953, 2916, 2869, 2828, 1607,
CHFlu-9), 6.86 (d, J = 2.0 Hz, 1H, CHIm), 6.54 (d, J = 2.0 Hz, 1H, 1489, 1450, 1381, 1301, 1233, 1220, 955, 860, 824, 732,
CHIm), 2.39 (s, 3H, CH3 para), 2.13 (s, 6H, CH3 ortho); 13C{1H} 697 cm−1; MS (ESI): m/z (%): 561 (100) [M − Cl]+; elemental ana-
NMR (105.5 MHz, CD2Cl2): δ = 173.2 (N2C), 141.9, 141.1, 140.4, lysis calcd (%) for C33H34ClN2Rh (MW = 597.00) + 0.25 CH2Cl2:
135.4, 135.2 (CAr), 130.3, 129.7, 128.7 (2 CHFlu + CHMes), 125.3 C 64.60, H 5.62, N 4.53; found: C 64.40, H 5.92, N 4.33.
(CHFlu), 123.5 (CHIm), 121.0 (CHFlu), 118.6 (CHIm), 65.4 (CHFlu-9),
21.3 (CH3 para), 18.0 (CH3 ortho); IR (ATR): ν = 3159, 3133, 3039, fluoren-9-yl)rhodium(I) (5′). A solution of compound
Chloro-(η4-cycloocta-1,5-diene)-(9-(1-mesitylimidazolium-3-yl)-
2
2916, 1722, 1606, 1553, 1486, 1446, 1418, 1407, 1377, 1304, (30.5 mg, 87 μmol) in CD2Cl2 (0.8 mL) pre-cooled at −80 °C
1224, 1211, 1031, 950, 856, 824, 739, 734, 696 cm−1; MS (ESI): was slowly transferred via a cannula into an NMR tube con-
m/z (%): 588 (100) [M − Cl + MeCN]+; elemental analysis calcd taining solid [RhCl(COD)]2 (21.5 mg, 43 μmol, 1.0 eq.) placed
(%) for C25H22AuCl (MW = 582.87) + 0.75 CH2Cl2: C 47.83, H in a cold bath at −80 °C. The NMR tube was rapidly shaken
3.66, N 4.33; found: C 47.80, H 3.65, N 4.18.
and kept at this temperature until its introduction into the
(9-(1-Mesitylimidazolium-3-yl)fluoren-9-yl)gold(I)
chloride NMR spectrometer with the probe temperature set up and
(4′). Solid AuCl(tht) (25 mg, 0.078 mmol) was added all at stabilized at 193 K. The complete NMR data were recorded at
once into a solution of 2 (29 mg, 0.083 mmol, 1.05 eq.) in this temperature and indicated a mixture consisting of com-
CD2Cl2 (0.8 mL) at −80 °C. The reaction mixture was then plexes 5′ and 5 in a ∼1/1 ratio along with excess [RhCl(COD)]2
transferred to a NMR tube placed in a cold bath at −80 °C. The (due to the incomplete transfer of the solution of 2). Warming
NMR tube was kept at this temperature until its introduction up the solution to room temperature gave a quantitative and
into the NMR spectrometer with the probe temperature set up clean conversion into complex 5. NMR data for complex 5′ are
1
and stabilized at 214 K. The following NMR data were recorded as follows: H NMR (500 MHz, CD2Cl2, 193 K): δ = 9.18 (br s,
at this temperature. 1H NMR (400 MHz, CD2Cl2, 214 K): δ = 1H, N2CH), 7.85–7.79 (m, 3H, CHFlu), 7.38–7.31 (m, 1H, CHFlu),
9.36 (s, 1H, N2CH), 7.82–7.76 (m, 2H, CHFlu), 7.41–7.37 (m, 2H, 7.31–7.22 (m, 4H, CHFlu), 7.05 (s, 2H, CHMes), 6.93 (s, 1H,
CHFlu), 7.35–7.28 (m, 4H, CHFlu), 7.06 (s, 1H, CHIm), 7.05 (s, CHIm), 4.16 (br s, 3H, CHCOD), 3.88 (br s, 1H, CHCOD), 2.33 (s,
2H, CHMes), 6.60 (s, 1H, CHIm), 2.34 (s, 3H, CH3 para), 2.05 (s, 3H, CH3 para), 2.16 (br s, 6H, CH3 ortho), 2.41–1.23 (m, 8H,
6H, CH3 ortho); 13C{1H} NMR (105.5 MHz, CD2Cl2, 214 K): δ = CH2 COD); 13C{1H} NMR (125.8 MHz, CD2Cl2, 193 K): δ = 142.9,
148.7, 140.9 (CAr), 138.3 (N2CH), 136.0, 134.3, 130.3 (CAr), 129.2 141.0, 140.0, 138.7, 136.3, (CAr), 137.4 (br, N2CH), 135.2, 134.7
(CHMes), 126.6 (CHFlu), 126.1 (CHFlu), 123.7 (CHIm), 123.2 (CAr), 129.0 (CHMes), 127.8, 127.7, 125.2, 123.6 (CHFlu), 120.4
(CHFlu), 121.9 (CHIm), 120.1(CHFlu), 71.1 (Au-CFlu-9), 20.9 (CHIm), 119.6 (CHFlu), 86.1 (br, CHCOD), 77.1 (d, JRh–C = 10.1
(CH3 para), 17.3 (CH3 ortho).
Hz, CHCOD), 73.8 (d, JRh–C = 21.1 Hz, Rh-CFlu-9), 31.4, 30.5, 29.3
Chloro-(η4-cycloocta-1,5-diene)-(1-mesityl-3-(fluoren-9-yl)- (CH2 COD), 21.0 (CH3 para), 15.2 (CH3 ortho).
imidazol-2-ylidene) rhodium(I) (5). Solid [RhCl(1,5-COD)]2
(1-Mesityl-3-(fluoren-9-yl)imidazol-2-ylidene)silver(I) bromide
(102 mg, 0.206 mmol) was added all at once into a solution of (6). CH2Cl2 (10 mL) was syringed into solid imidazolium
mesoionic 2 (159 mg, 0.453 mmol, 2.2 eq.) in CH2Cl2 (12 mL) bromide 1 (249 mg, 0.577 mmol), silver(I) oxide (80 mg,
This journal is © The Royal Society of Chemistry 2014
Dalton Trans., 2014, 43, 4474–4482 | 4479